Sumitomo Mitsui Trust Group Inc. raised its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 6,166,709 shares of the company’s stock after acquiring an additional 23,765 shares during the period. Procter & Gamble accounts for about 0.5% of Sumitomo Mitsui Trust Group Inc.’s holdings, making the stock its 26th biggest position. Sumitomo Mitsui Trust Group Inc. owned 0.26% of Procter & Gamble worth $947,515,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Kingstone Capital Partners Texas LLC increased its stake in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Norges Bank purchased a new position in shares of Procter & Gamble during the 2nd quarter worth about $5,099,644,000. Laurel Wealth Advisors LLC grew its holdings in Procter & Gamble by 15,971.7% in the second quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock valued at $1,117,270,000 after purchasing an additional 6,969,110 shares during the period. Vanguard Group Inc. grew its holdings in Procter & Gamble by 1.4% in the second quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after purchasing an additional 3,189,111 shares during the period. Finally, Invesco Ltd. increased its position in Procter & Gamble by 21.4% during the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after purchasing an additional 2,880,895 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the company. Dbs Bank upgraded Procter & Gamble to a “hold” rating in a report on Friday, December 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Bank of America dropped their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating for the company in a research report on Thursday, December 18th. Finally, UBS Group cut their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Fifteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $169.23.
Insider Transactions at Procter & Gamble
In other news, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.20% of the stock is owned by insiders.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Seeking Alpha argues the market is wrong and P&G is a buy — the piece upgrades the rating, highlighting durable cash flows and long-term compounding potential that could attract value investors. Procter & Gamble: The Market Is Wrong – It’s Time To Buy This Compounder (Rating Upgrade)
- Positive Sentiment: TD Cowen cut its price target (to $150) but maintained a Buy — signals some near-term valuation cooling yet continued analyst conviction that P&G has upside from current levels. Benzinga
- Neutral Sentiment: Zacks notes P&G is a trending stock and summarizes factors investors should watch (demand trends, promotions, dividend profile), useful for short-term traders but not a firm directional catalyst. Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
- Neutral Sentiment: Analysis on Yahoo Finance frames the story as a trade-off: legal scrutiny vs. new CEO emphasis on pricing — legal risk raises uncertainty, but stronger pricing execution would support margins and investor confidence. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
- Negative Sentiment: Regulatory action: P&G agreed to change Crest kids’ toothpaste packaging after concerns raised by the Texas AG — this creates near-term legal/regulatory overhang and potential reputational risk. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Negative Sentiment: Wells Fargo trimmed its price target (to $158 from $170) as 2026 models were reset — the cut, even with an Overweight call, signals lower near-term upside from previous analyst expectations. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
- Negative Sentiment: Market-watch pieces and a Seeking Alpha “still not a buy” write-up highlight valuation concerns (multiples vs. growth) and recent softness in category demand — these narratives feed selling pressure and explain continued volatility. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
- Negative Sentiment: Short-term technical/market signal: coverage flagged P&G hitting a 52-week low recently, which can amplify downside momentum as momentum traders and funds react. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?
Procter & Gamble Trading Up 0.2%
NYSE:PG opened at $141.81 on Monday. Procter & Gamble Company has a one year low of $137.62 and a one year high of $179.99. The business’s 50-day simple moving average is $144.93 and its 200 day simple moving average is $151.45. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The stock has a market cap of $331.37 billion, a price-to-earnings ratio of 20.70, a price-to-earnings-growth ratio of 4.79 and a beta of 0.39.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s payout ratio is currently 61.75%.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Do not delete, read immediately
- Trump Planning to Use Public Law 63-43: Prepare Now
- Huge robotics rollout underway
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
